| Dauendorffer JN, Dupuy A
Radiation recall dermatitis induced by erlotinib. [JOURNAL ARTICLE]
J Am Acad Dermatol 2009 Dec; 61(6):1086.
Full Citation | Find Related Articles |
| Mitsudomi T, Yatabe Y
Epidermal growth factor receptor in relation to tumor development: EGFR gene and cancer. [JOURNAL ARTICLE]
FEBS J 2009 Nov 18.
Abstract | Full Citation | Find Related Articles |
| Okamoto I
Epidermal growth factor receptor in relation to tumor development: EGFR-targeted anticancer therapy. [JOURNAL ARTICLE]
FEBS J 2009 Nov 18.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Choi YJ, Rho JK, Jeon BS, et al.
Combined inhibition of IGFR enhances the effects of gefitinib in H1650: a lung cancer cell line with EGFR mutation and primary resistance to EGFR-TK inhibitors. [JOURNAL ARTICLE]
Cancer Chemother Pharmacol 2009 Nov 18.
Abstract | Full Citation |
| Huang X, Patel S, Ahmed N, et al.
Severe toxicity of skin rash, fever and diarrhea associated with imatinib: case report and review of skin toxicities associated with tyrosine kinase inhibitors. [JOURNAL ARTICLE]
Drug Des Devel Ther 2009.:215-219.
Abstract | Full Citation | Find Related Articles |
| Azzoli CG, Baker S, Temin S, et al.
American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small-Cell Lung Cancer. [JOURNAL ARTICLE]
J Clin Oncol 2009 Nov 16.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Seike M
MicroRNA Expression Profiles in Lung Cancer Cooperated with Drug Sensitivity to EGFR Tyrosine Kinase Inhibitor. [Journal Article]
J Nippon Med Sch 2009 Oct; 76(5):275-6.
Abstract | Full Citation |
| Lv PC, Zhou CF, Chen J, et al.
Design, synthesis and biological evaluation of thiazolidinone derivatives as potential EGFR and HER-2 kinase inhibitors. [JOURNAL ARTICLE]
Bioorg Med Chem 2009 Oct 30.
Abstract | Full Citation | Find Related Articles |
| Sparidans RW, Iusuf D, Schinkel AH, et al.
Liquid chromatography-tandem mass spectrometric assay for the light sensitive tyrosine kinase inhibitor axitinib in human plasma. [JOURNAL ARTICLE]
J Chromatogr B Analyt Technol Biomed Life Sci 2009 Oct 30.
Abstract | Full Citation | Find Related Articles |
| Stepanski EJ, Houts AC, Schwartzberg LS, et al.
Second- and Third-line Treatment of Patients With Non-Small-Cell Lung Cancer With Erlotinib in the Community Setting: Retrospective Study of Patient Healthcare Utilization and Symptom Burden. [Journal Article]
Clin Lung Cancer 2009 Nov; 10(6):426-32.
Abstract | Full Citation |
  |
